Literature DB >> 11263528

Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis.

C Agard1, C Ligeza, B Dupas, A Izembart, C El Kouri, P Moullier, N Ferry.   

Abstract

Gene transfer of the herpes simplex virus thymidine kinase (HSV-tk) gene sensitizes tumor cells to the toxic effect of ganciclovir (GCV). The toxic effect of GCV extends to nontransduced surrounding cells by a metabolic process known as the bystander effect. A distant bystander effect, which involves anatomically separated tumors, has been reported in vivo. Our aim was to evaluate and characterize such distant effect in a rat model of colorectal tumors implanted in the liver using adenovirus to carry the HSV-tk gene. Two colorectal tumors were implanted in two distinct liver lobes of the liver. One of the tumor was transduced with an adenoviral vector containing HSV-tk gene. The volumes of the tumors were monitored after GCV treatment. Implication of the immune system was studied histologically and after in vivo manipulations. After GCV administration, the nontransduced distant tumor regressed partially or completely in the experimental group. Immunohistochemical analysis revealed the presence of CD8+ lymphocytes in the distant lesion. HSV-tk/GCV-induced immune response against tumors was evidenced by an adoptive transfer assay (Winn assay) and the distant bystander effect was blunted after CD8+ lymphocytes depletion. However, the survival rates for treated animals were not improved. These findings demonstrate that an immune-mediated effective distant bystander effect can be obtained after limited adenoviral-mediated transfer of the HSV-tk gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263528     DOI: 10.1038/sj.cgt.7700281

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  13 in total

Review 1.  Progress and problems with the use of suicide genes for targeted cancer therapy.

Authors:  Zahra Karjoo; Xuguang Chen; Arash Hatefi
Journal:  Adv Drug Deliv Rev       Date:  2015-05-22       Impact factor: 15.470

2.  Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancer.

Authors:  Long-Ying Deng; Jian-Ping Wang; Zhi-Fu Gui; Li-Zong Shen
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 3.  Introduction to the background, principles, and state of the art in suicide gene therapy.

Authors:  Ion Niculescu-Duvaz; Caroline J Springer
Journal:  Mol Biotechnol       Date:  2005-05       Impact factor: 2.695

Review 4.  Gene therapy of liver cancer.

Authors:  Ruben Hernandez-Alcoceba; Bruno Sangro; Jesus Prieto
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

5.  Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.

Authors:  E Antonio Chiocca; Laura K Aguilar; Susan D Bell; Balveen Kaur; Jayson Hardcastle; Robert Cavaliere; John McGregor; Simon Lo; Abhik Ray-Chaudhuri; Arnab Chakravarti; John Grecula; Herbert Newton; Kimbra S Harris; Robert G Grossman; Todd W Trask; David S Baskin; Carissa Monterroso; Andrea G Manzanera; Estuardo Aguilar-Cordova; Pamela Z New
Journal:  J Clin Oncol       Date:  2011-08-15       Impact factor: 44.544

6.  Increased anti-tumor effect by a combination of HSV thymidine kinase suicide gene therapy and interferon-gamma/GM-CSF cytokine gene therapy in CT26 tumor model.

Authors:  Sung Hyun Yang; Tae Keun Oh; Seung Taik Kim
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

Review 7.  Glioma virus therapies between bench and bedside.

Authors:  Johanna K Kaufmann; E Antonio Chiocca
Journal:  Neuro Oncol       Date:  2014-01-26       Impact factor: 12.300

Review 8.  Recent progress in the research of suicide gene therapy for malignant glioma.

Authors:  Ryota Tamura; Hiroyuki Miyoshi; Kazunari Yoshida; Hideyuki Okano; Masahiro Toda
Journal:  Neurosurg Rev       Date:  2019-11-28       Impact factor: 3.042

9.  Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.

Authors:  Lee A Wheeler; Andrea G Manzanera; Susan D Bell; Robert Cavaliere; John M McGregor; John C Grecula; Herbert B Newton; Simon S Lo; Behnam Badie; Jana Portnow; Bin S Teh; Todd W Trask; David S Baskin; Pamela Z New; Laura K Aguilar; Estuardo Aguilar-Cordova; E Antonio Chiocca
Journal:  Neuro Oncol       Date:  2016-02-02       Impact factor: 12.300

10.  Bystander-mediated regression of murine neuroblastoma via retroviral transfer of the HSV-TK gene.

Authors:  Hyun-Sang Cho; Hye-Ran Lee; Moon Kyu Kim
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.